Coripharma

@coripharma

Coripharma’s experienced team offers contract manufacturing and development services to pharmaceutical companies all over the world.

Vrijeme pridruživanja: travanj 2019.

Tweetovi

Blokirali ste korisnika/cu @coripharma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @coripharma

  1. 31. sij

    Coripharma and Midas to cooperate on sales & marketing for pharmaceutical contract manufacturing of finished dosage forms.

    Poništi
  2. 3. pro 2019.

    Coripharma today announced an agreement with STADA to package 700 million tablets annually for three years, starting this month.

    Poništi
  3. 1. srp 2019.
    Poništi
  4. 23. svi 2019.

    Following the recent R&D acquisition, Thora Bjorg Magnusdottir is joining Coripharma's executive management team.

    Poništi
  5. 13. svi 2019.

    Generics Bulletin: By buying Actavis’ local R&D activities, Coripharma is seeking to become a full-service generics contract development and manufacturing organization.

    Poništi
  6. 6. svi 2019.

    Coripharma acquires Actavis’ former R&D site from Teva, with a portfolio of active R&D projects, production & laboratory equipment, and buildings. Coripharma already owns a pharmaceutical manufacturing plant on the same Iceland site.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·